{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:59:12Z","timestamp":1790629152031,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Paracelsus Medical University","id":[{"id":"https:\/\/ror.org\/03z3mg085","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) prophylaxis is a key component of neurosurgical care, with low-molecular-weight heparins (LMWHs) representing the standard pharmacological approach. While enoxaparin is well established, the evidence regarding the efficacy and safety of tinzaparin in neurosurgical patients remains limited. This study aimed to compare the incidence of VTE and postoperative rebleeding between enoxaparin and tinzaparin in a large cohort of neurosurgical patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following a standardized institutional switch from enoxaparin to tinzaparin in 2021, we conducted a retrospective cohort study including all adult patients undergoing neurosurgical procedures during the 2.5-year periods before and after the change. Patients were stratified according to their perioperative VTE risk. The primary outcome was imaging-confirmed symptomatic VTE during hospitalization, and the secondary outcome was postoperative rebleeding requiring surgical evacuation. A multivariable logistic regression analysis was performed to adjust for potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 4,888 patients were included. Overall, 51 symptomatic VTE events occurred (1.04%). In low risk patients (Group A), VTE incidence did not differ significantly between enoxaparin and tinzaparin (0.44% vs. 0.86%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.35). In moderate-to-high risk patients (Group B), VTE occurred significantly more frequently with tinzaparin than enoxaparin (1.67% vs. 0.84%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), driven predominantly by PE (1.05% vs. 0.18%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01), while DVT rates were comparable (0.62% vs. 0.67%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.87). Multivariable analysis in Group B confirmed lower odds of VTE with enoxaparin (OR 0.475, 95% CI 0.246\u20130.919,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.027). Postoperative rebleeding rates did not differ significantly between treatment groups. The increase in PE coincided with increased CTA utilization and showed no clear temporal step change following the switch to tinzaparin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both enoxaparin and tinzaparin were associated with low VTE rates and comparable postoperative rebleeding rates. Although higher VTE rates with tinzaparin were observed in the medium-to-high risk group, the predominance of PE, increased CTA utilization, and absence of a temporal step change limit a causal interpretation. These findings should therefore be considered hypothesis-generating rather than evidence of superior efficacy of either agent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00701-026-07027-7","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:46:05Z","timestamp":1790304365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes following a hospital-wide transition from enoxaparin to tinzaparin for venous thromboembolism prophylaxis in neurosurgical patients"],"prefix":"10.1007","volume":"168","author":[{"given":"Leonard","family":"Ritter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Liebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl M.","family":"Schebesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"2","key":"7027_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJM199807093390204","volume":"339","author":"G Agnelli","year":"1998","unstructured":"Agnelli G, Piovella F, Buoncristiani P et al (1998) Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339(2):80\u20135. https:\/\/doi.org\/10.1056\/NEJM199807093390204","journal-title":"N Engl J Med"},{"issue":"23","key":"7027_CR2","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","volume":"3","author":"DR Anderson","year":"2019","unstructured":"Anderson DR, Morgano GP, Bennett C et al (2019) American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 3(23):3898\u20133944. https:\/\/doi.org\/10.1182\/bloodadvances.2019000975","journal-title":"Blood Adv"},{"key":"7027_CR3","doi-asserted-by":"publisher","first-page":"e1102","DOI":"10.1016\/j.wneu.2018.10.237","volume":"122","author":"IA Buchanan","year":"2019","unstructured":"Buchanan IA, Lin M, Donoho DA et al (2019) Predictors of venous thromboembolism after nonemergent craniotomy: a nationwide readmission database analysis. World Neurosurg 122:e1102\u2013e1110. https:\/\/doi.org\/10.1016\/j.wneu.2018.10.237","journal-title":"World Neurosurg"},{"issue":"5","key":"7027_CR4","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","volume":"162","author":"JD Douketis","year":"2022","unstructured":"Douketis JD, Spyropoulos AC, Murad MH et al (Nov2022) Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest 162(5):e207\u2013e243. https:\/\/doi.org\/10.1016\/j.chest.2022.07.025","journal-title":"Chest"},{"issue":"31\u201332","key":"7027_CR5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3238\/arztebl.2016.0532","volume":"113","author":"A Encke","year":"2016","unstructured":"Encke A, Haas S, Kopp I (2016) The Prophylaxis of Venous Thromboembolism. Dtsch Arztebl Int 113(31\u201332):532\u2013538. https:\/\/doi.org\/10.3238\/arztebl.2016.0532","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"7027_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1055\/s-0038-1653787","volume":"73","author":"BI Eriksson","year":"1995","unstructured":"Eriksson BI, Soderberg K, Widlund L, Wandeli B, Tengborn L, Risberg B (1995) A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers. Thromb Haemost 73(3):398\u2013401","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"7027_CR7","first-page":"77","volume":"22","author":"J Fareed","year":"1996","unstructured":"Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM (1996) Are the available low-molecular-weight heparin preparations the same? Semin Thromb Hemost 22(Suppl 1):77\u201391","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"7027_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14444\/7011","volume":"14","author":"CR Fischer","year":"2020","unstructured":"Fischer CR, Wang E, Steinmetz L et al (2020) Prevalence of risk factors for hospital-acquired venous thromboembolism in neurosurgery and orthopedic spine surgery patients. Int J Spine Surg 14(1):79\u201386. https:\/\/doi.org\/10.14444\/7011","journal-title":"Int J Spine Surg"},{"issue":"4","key":"7027_CR9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23867","volume":"14","author":"DR Hallan","year":"2022","unstructured":"Hallan DR, Sciscent B, Rizk E (2022) A retrospective comparative cohort study of craniotomy and prophylactic enoxaparin timing. Cureus 14(4):e23867. https:\/\/doi.org\/10.7759\/cureus.23867","journal-title":"Cureus"},{"issue":"5 Suppl","key":"7027_CR10","doi-asserted-by":"publisher","first-page":"445S","DOI":"10.1378\/chest.114.5_supplement.445s","volume":"114","author":"J Hirsh","year":"1998","unstructured":"Hirsh J, Dalen JE, Anderson DR et al (Nov1998) Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 114(5 Suppl):445S-469S. https:\/\/doi.org\/10.1378\/chest.114.5_supplement.445s","journal-title":"Chest"},{"key":"7027_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/5584_2016_117","volume":"906","author":"M Jeraq","year":"2017","unstructured":"Jeraq M, Cote DJ, Smith TR (2017) Venous Thromboembolism in Brain Tumor Patients. Adv Exp Med Biol 906:215\u2013228. https:\/\/doi.org\/10.1007\/5584_2016_117","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"7027_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/ajns.AJNS_351_19","volume":"15","author":"A Kaewborisutsakul","year":"2020","unstructured":"Kaewborisutsakul A, Tunthanathip T, Yuwakosol P, Inkate S, Pattharachayakul S (2020) Incidence and risk factors for venous thromboembolism following craniotomy for intracranial tumors: a cohort study. Asian J Neurosurg 15(1):31\u201338. https:\/\/doi.org\/10.4103\/ajns.AJNS_351_19","journal-title":"Asian J Neurosurg"},{"issue":"4","key":"7027_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3171\/2017.2.JNS162040","volume":"129","author":"NR Khan","year":"2018","unstructured":"Khan NR, Patel PG, Sharpe JP, Lee SL, Sorenson J (2018) Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis. J Neurosurg 129(4):906\u2013915. https:\/\/doi.org\/10.3171\/2017.2.JNS162040","journal-title":"J Neurosurg"},{"issue":"4","key":"7027_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","volume":"41","author":"SV Konstantinides","year":"2019","unstructured":"Konstantinides SV, Meyer G, Becattini C et al (2019) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41(4):543\u2013603. https:\/\/doi.org\/10.1093\/eurheartj\/ehz405","journal-title":"Eur Heart J"},{"issue":"22","key":"7027_CR15","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1182\/bloodadvances.2018024828","volume":"2","author":"W Lim","year":"2018","unstructured":"Lim W, Le Gal G, Bates SM et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv 2(22):3226\u20133256. https:\/\/doi.org\/10.1182\/bloodadvances.2018024828","journal-title":"Blood Adv"},{"issue":"6","key":"7027_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.thromres.2007.07.004","volume":"122","author":"S Middeldorp","year":"2008","unstructured":"Middeldorp S (2008) Heparin: from animal organ extract to designer drug. Thromb Res 122(6):753\u2013762. https:\/\/doi.org\/10.1016\/j.thromres.2007.07.004","journal-title":"Thromb Res"},{"issue":"7","key":"7027_CR17","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","volume":"88","author":"P Mismetti","year":"2001","unstructured":"Mismetti P, Laporte S, Darmon JY, Buchmuller A, Decousus H (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88(7):913\u201330. https:\/\/doi.org\/10.1046\/j.0007-1323.2001.01800.x","journal-title":"Br J Surg"},{"issue":"8","key":"7027_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/EJA.0000000000002009","volume":"41","author":"L Mora","year":"2024","unstructured":"Mora L, Gaudet JG, Bilotta F, Bruder N (2024) European guidelines on peri-operative venous thromboembolism prophylaxis: first update.: chapter 6: neurosurgery. Eur J Anaesthesiol 41(8):594\u2013597. https:\/\/doi.org\/10.1097\/EJA.0000000000002009","journal-title":"Eur J Anaesthesiol"},{"key":"7027_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103628","volume":"77","author":"P Parmontree","year":"2022","unstructured":"Parmontree P, Ketprathum P, Ladnok T, Meeaium S, Thanaratsiriworakul T, Sonhorm U (May2022) Predictive risk factors for venous thromboembolism in neurosurgical patients: A retrospective analysis single center cohort study. Ann Med Surg (Lond) 77:103628. https:\/\/doi.org\/10.1016\/j.amsu.2022.103628","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"7027_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0037-1614411","volume":"81","author":"A Planes","year":"1999","unstructured":"Planes A, Samama MM, Lensing AW et al (Jan1999) Prevention of deep vein thrombosis after hip replacement\u2013comparison between two low-molecular heparins, tinzaparin and enoxaparin. Thromb Haemost 81(1):22\u201325","journal-title":"Thromb Haemost"},{"issue":"5","key":"7027_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00063-023-01018-7","volume":"118","author":"G Soffker","year":"2023","unstructured":"Soffker G, Janssens U, Kluge S (2023) 10 Kernaussagen zur S2k-Leitlinie \u201cDiagnostik und Therapie der Venenthrombose und der Lungenembolie.\u201d Med Klin Intensivmed Notfmed 118(5):362\u2013365. https:\/\/doi.org\/10.1007\/s00063-023-01018-7. ([Ten key messages of the S2k guideline on diagnostics and therapy of venous thrombosis and pulmonary embolism])","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"2","key":"7027_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/10790268.2021.1913561","volume":"46","author":"B Wei","year":"2023","unstructured":"Wei B, Zhou H, Liu G et al (2023) Risk factors for venous thromboembolism in patients with spinal cord injury: a systematic review and meta-analysis. J Spinal Cord Med 46(2):181\u2013193. https:\/\/doi.org\/10.1080\/10790268.2021.1913561","journal-title":"J Spinal Cord Med"},{"issue":"1","key":"7027_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1365-2141.2003.04196.x","volume":"121","author":"RH White","year":"2003","unstructured":"White RH, Ginsberg JS (2003) Low-molecular-weight heparins: are they all the same? Br J Haematol 121(1):12\u201320. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04196.x","journal-title":"Br J Haematol"},{"issue":"2","key":"7027_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/neurolint13020021","volume":"13","author":"F Wilhelmy","year":"2021","unstructured":"Wilhelmy F, Hantsche A, Gaier M et al (2021) Tinzaparin vs. nadroparin safety and efficacy in neurosurgery. Neurol Int 13(2):202\u2013206. https:\/\/doi.org\/10.3390\/neurolint13020021","journal-title":"Neurol Int"},{"issue":"4","key":"7027_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MBC.0000000000001300","volume":"35","author":"H Wu","year":"2024","unstructured":"Wu H, Zhou L, Wang Q, Wang T, Liang S (2024) Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis. Blood Coagul Fibrinolysis 35(4):187\u2013195. https:\/\/doi.org\/10.1097\/MBC.0000000000001300","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-026-07027-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-026-07027-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-026-07027-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:02:46Z","timestamp":1790625766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-026-07027-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7027"],"URL":"https:\/\/doi.org\/10.1007\/s00701-026-07027-7","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived due to the study\u2019s retrospective design. No additional data was collected. The study was approved by the Institutional Review Board of Paracelsus Medical University.","order":2,"name":"Ethics","label":"Consent to participate\/Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"223"}}